Clinical Trials Browser

Recruiting × Lymphoma, Follicular × Sarcoma × Clear all

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Pyloric Stenosis, Hypertrophic, Dendritic Cell Sarcoma, Interdigitating

NCT07249905 2026-03-03

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Phase 1/2 Recruiting

180 enrolled

LymphoidSarcoma

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Dendritic Cell Sarcoma, Interdigitating

NCT07121946 2026-02-10

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Phase 1 Recruiting

42 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT04390737 2026-01-30

Evaluate the Safety and Clinical Activity of HH2853

Phase 1/2 Recruiting

254 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Sarcoma, Lymphoma, T-Cell, Peripheral

NCT06941194 2025-12-02

PRALISS

Phase NA Recruiting

48 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Sarcoma

NCT06712810 2025-10-10

Q702 for the Treatment of Patients With Hematologic Malignancies

Phase 1 Recruiting

46 enrolled

DermatologicLymphoidMyeloidOther hematologic neoplasmSarcoma

Blastic Plasmacytoid Dendritic Cell Neoplasm, Histiocytosis, Langerhans-Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelomonocytic, Chronic, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Erdheim-Chester Disease, Dendritic Cell Sarcoma, Interdigitating, Histiocytic Sarcoma, Primary Myelofibrosis

NCT06151080 2025-02-19

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

Phase 2 Recruiting

38 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Dendritic Cell Sarcoma, Interdigitating

NCT06287398 2024-07-22

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

Phase 2 Recruiting

39 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Recurrence, Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

SynKIR-310 for Relapsed/Refractory B-NHL

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Evaluate the Safety and Clinical Activity of HH2853

PRALISS

Q702 for the Treatment of Patients With Hematologic Malignancies

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL